Karen developed and launched new genomic products in the microarray space at numerous Life Sciences companies including Packard BioChip, PerkinElmer and GeneXP Biosciences. She was part of and led strategic business development and partnership efforts at several genomic services laboratories including Icoria, Cogenics, Beckman Coulter Genomics, Covance and Generation Health. Karen was instrumental in multimillion-dollar sales that lead to the 2009 acquisition of Cogenics by Beckman Coulter as well as the successful commercialization and launch of Covance Genomics services after the acquisition of Merck’s Rosetta operation in Seattle. After her time with Covance Genomics, Karen was VP of Strategic Operations and Account Management at Generation Health (acquired by CVS Caremark) and it’s spin-out MetaDiagnostic delivering molecular diagnostic test developers the key clinical utility, health outcome and cost effectiveness evidence data crucial to support their diagnostic test reimbursement by payers. Karen is currently the Vice President of Business Development at Shoreline Biome, a leading edge company developing microbiome kits and software to advance the use of NGS in microbiome translational research. Karen has a Ph.D.in Microbiology and Molecular Genetics from the University of Massachusetts.